This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas. The ...

Please provide your email address to receive an email when new articles are posted on . Prolonged use of medroxyprogesterone acetate injection associated with a 5.6-fold increased risk. Use of ...

The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns. Depo-Provera ...

Hundreds of women in the UK are considering taking legal action over fears a contraceptive jab has put them at risk of a potentially fatal brain tumour. Every month, about 10,000 prescriptions are ...

Risk factors for repeat pregnancy terminations include teenage pregnancy, social deprivation, two or more previous live births or miscarriages at the time of the initial termination, and the use of ...

A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...

Recent scientific research has uncovered a significant association between the long-term use of Depo-Provera, a widely used injectable contraceptive, and the development of meningiomas, tumors ...

Evidence indicates that Depo-Provera can cause specific mutations in women's DNA. Given the availability of alternatives without this known risk, the continued use of the shot difficult to justify.” — ...

THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients ...

Christopher O'Sullivan does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

The choice of safe and highly effective contraception for women who have special medical conditions can pose tremendous challenges. Viral hepatitis such as hepatitis C virus (HCV) is a major public ...